Darwin Lee

Glyco-engineered Long Acting FGF21 Variant with Optimal Pharmaceutical and Pharmacokinetic Properties to Enable Weekly to Twice Monthly Subcutaneous Dosing

Jeffrey R. Chabot, Denise M O'Hara, W. Somers, 2018, Scientific Reports.

Fibroblast Growth Factor 21 Improves Insulin Sensitivity and Synergizes with Insulin in Human Adipose Stem Cell-Derived (hASC) Adipocytes

Dongmei Li, Yimin Zhu, B. Goodwin, 2014, PloS one.

Glyco-engineered Long Acting FGF21 Variant with Optimal Pharmaceutical and Pharmacokinetic Properties to Enable Weekly to Twice Monthly Subcutaneous Dosing

Jeffrey R. Chabot, Denise M O'Hara, W. Somers, 2018, Scientific Reports.